Type 2 diabetes (T2DM), Alzheimer's disease (AD), and insulin resistance are age‐related
conditions and increased prevalence is of public concern. Recent research has provided …

A growing body of evidence links type-2 diabetes (T2D) with dementia and
neurodegenerative diseases such as Alzheimer's disease (AD). AD is the most common …

Background Alzheimer's disease (AD) pathology begins several years before the clinical
onset. The long preclinical phase is composed of three stages according to the …

Abstract The Alzheimer's Disease Neuroimaging Initiative (ADNI) is an ongoing,
longitudinal, multicenter study designed to develop clinical, imaging, genetic, and …

The human brain is composed of functional networks that have a modular topology, where
brain regions are organized into communities that form internally dense (segregated) and …

Abstract Introduction The Alzheimer's Disease Neuroimaging Initiative (ADNI) separates
“early” and “late” mild cognitive impairment (MCI) based on a single memory test. We …

This study was designed to evaluate whether subjects with amyloid beta (Aβ) pathology,
detected using florbetapir positron emission tomorgraphy (PET), demonstrated greater …

Objective: Our goal was to evaluate the association of APOE with amyloid deposition,
cerebrospinal fluid levels (CSF) of Aβ, tau, and p-tau, brain atrophy, cognition and cognitive …

Degeneration of basal forebrain (BF) cholinergic nuclei is associated with cognitive decline,
and this effect is believed to be mediated by neuronal dysfunction in the denervated cortical …

Feature selection for multiple types of data has been widely applied in mild cognitive
impairment (MCI) and Alzheimer's disease (AD) classification research. Combining multi …